dermatology brochure v19
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
®<br />
cephacare<br />
clavubactin ®<br />
trimacare® amoxycare ®<br />
®<br />
prednicare<br />
fungiconazol ®<br />
®<br />
marbocare<br />
marbofloxacin<br />
marbocare ® -<br />
for superficial and deep pyoderma<br />
• Bactericidal activity against Gram -ve and Gram +ve pathogens<br />
• Highly active against S.pseudintermedius, the pathogen responsible for 90% of pyodermas 5<br />
• Deep pyoderma Gram -ve infections may be more common than previously thought 5<br />
• Antibiotic plasma levels from a single dose are well above the MIC 90 for S.pseudintermedius 6<br />
- reaches higher concentrations in skin than plasma (1:6 ratio in the dog)<br />
• High efficacy in challenging clinical cases 6<br />
• 5mg licensed in cats for wounds and abscesses<br />
5mg<br />
20mg<br />
80mg<br />
Dosing accuracy to match<br />
the weight of animal<br />
Tablets for cats<br />
and small dogs *<br />
4-way split<br />
SmartTabs ®<br />
2-way split<br />
tablets for dogs<br />
Dosage<br />
2mg/kg bodyweight<br />
once daily<br />
5. Mueller R.S. and Stephan B., Pradofloxacin in the treatment of canine deep pyoderma: a multicentered, blinded, randomised parallel trial, journal compilation (2007) ESVD and ACVD.<br />
6. Carlotti D.N. et al., Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs, JSAP (1999) 40, 265-270.
Change language